PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d\'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy.\', \'ASL Città di Torino, Italy.\', \'CMID, Centre of Research of Immunopathology and Rare Diseases, Coordinating Centre of the Network for Rare Diseases of Piemonte and Valle d\'Aosta, ASL Città di Torino, Department of Clinical and Biological Sciences, University of Torino, and ASL Città di Torino, Italy. dario.roccatello@unito.it.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Clinical and experimental rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 32359035
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 85
?:title
  • Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32359035>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32359035>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all